The changing face of septic arthritis complicating rheumatoid arthritis in the era of biotherapies. Retrospective single-center study over 35years

Characteristics of spontaneous coagulase-negative staphylococcal spondylodiscitis: a retrospective comparative study versus Staphylococcus aureus spondylodiscitis

Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients

Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases

Variations in the metabolome in response to disease activity of rheumatoid arthritis

Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France

The SAPHO syndrome: a single-center study of 41 adult patients

Three-decade trends in the distribution of organisms causing septic arthritis in native joints: single-center study of 374 cases

Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study

Should non-steroidal anti-inflammatory drugs be used continuously in ankylosing spondylitis?

[Palindromic rheumatism]

Vascular effects of nonsteroidal antiinflammatory drugs

Abatacept for Treatment of Rheumatoid Arthritis: Special Focus on the Elderly

Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis

Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis

Management of inflammatory rheumatic conditions in the elderly

Overview of biologic treatments in the elderly

Rheumatoid arthritis in the elderly in the era of tight control

Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study

Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis

Cardiovascular risk in rheumatoid arthritis

Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience

Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France)

Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures

Prevalence of Renal Impairment in Patients With Rheumatoid Arthritis: Results From a Cross-Sectional Multicenter Study

The validity and reliability of the Turkish version of the Fear of Pain Questionnaire for Children-Short Form (FOPQC-SF) in children and adolescents with juvenile idiopathic arthritis

The effect of corticosteroid treatment on bilateral idiopathic granulomatous mastitis

Investigation of lower extremity performance, balance, and fatigue in individuals with systemic lupus erythematosus: A comparative study

Temozolomide and unusual indications: review of literature

Rheumatoid arthritis in the elderly in the era of tight control